Totus Medicines

Advertisement

cGxPJobs Banner

Totus Medicines Reports Strong Phase 1b Clinical Results for TOS-358 in HR+/HER2- Breast Cancer

EMERYVILLE, Calif., May 6, 2026 Totus Medicines announced encouraging interim Phase 1b clinical data for its investigational therapy TOS-358...

By cGxPwire Editor
May 8, 2026

Read More

Advertisement

cGxPJobs

Directory